Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Humberto Contreras-Trujillo

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Opinion in Genetics & Development|July 18, 2015
New insights into the conserved mechanism of pluripotency maintenanceXingliang Zhou, Humberto Contreras-Trujillo, Qi-Long Ying
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2015
CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancerMing T Cheah, James Y Chen, Debashis Sahoo, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2013
Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell responseDiane Tseng, Jens-Peter Volkmer, Stephen B Willingham, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2012
Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcomaBadreddin Edris, Kipp Weiskopf, Anne K Volkmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2013
Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growthBadreddin Edris, Stephen B Willingham, Kipp Weiskopf, et al.
Cell Reports|May 20, 2014
In vivo clonal analysis reveals lineage-restricted progenitor characteristics in mammalian kidney development, maintenance, and regenerationYuval Rinkevich, Daniel T Montoro, Humberto Contreras-Trujillo, et al.
Nature Communications|November 12, 2021
Deciphering intratumoral heterogeneity using integrated clonal tracking and single-cell transcriptome analysesHumberto Contreras-Trujillo, Jiya Eerdeng, Samir Akre, et al.
Cell|June 19, 2026
Expansion and CAR engineering of granulocyte-monocyte progenitors for cellular immunotherapyShi Yue, Zheng Guo, Crystal Pan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Three differentiation states risk-stratify bladder cancer into distinct subtypesJens-Peter Volkmer, Debashis Sahoo, Robert K Chin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2012
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumorsStephen B Willingham, Jens-Peter Volkmer, Andrew J Gentles, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Opinion in Genetics & Development|July 18, 2015
New insights into the conserved mechanism of pluripotency maintenanceXingliang Zhou, Humberto Contreras-Trujillo, Qi-Long Ying
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2015
CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancerMing T Cheah, James Y Chen, Debashis Sahoo, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2013
Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell responseDiane Tseng, Jens-Peter Volkmer, Stephen B Willingham, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2012
Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcomaBadreddin Edris, Kipp Weiskopf, Anne K Volkmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2013
Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growthBadreddin Edris, Stephen B Willingham, Kipp Weiskopf, et al.
Cell Reports|May 20, 2014
In vivo clonal analysis reveals lineage-restricted progenitor characteristics in mammalian kidney development, maintenance, and regenerationYuval Rinkevich, Daniel T Montoro, Humberto Contreras-Trujillo, et al.
Nature Communications|November 12, 2021
Deciphering intratumoral heterogeneity using integrated clonal tracking and single-cell transcriptome analysesHumberto Contreras-Trujillo, Jiya Eerdeng, Samir Akre, et al.
Cell|June 19, 2026
Expansion and CAR engineering of granulocyte-monocyte progenitors for cellular immunotherapyShi Yue, Zheng Guo, Crystal Pan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Three differentiation states risk-stratify bladder cancer into distinct subtypesJens-Peter Volkmer, Debashis Sahoo, Robert K Chin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2012
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumorsStephen B Willingham, Jens-Peter Volkmer, Andrew J Gentles, et al.
Pageof 1